Mangoceuticals (MGRX) Short Interest Ratio & Short Volume → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free MGRX Stock Alerts $0.24 +0.02 (+9.05%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Mangoceuticals Short Interest DataCurrent Short Volume45,700 sharesPrevious Short Volume197,600 sharesChange Vs. Previous Month-76.87%Dollar Volume Sold Short$11,109.67Short Interest Ratio / Days to Cover0.1Last Record DateApril 30, 2024Outstanding Shares24,620,000 sharesFloat Size14,140,000 sharesShort Percent of Float0.32%Today's Trading Volume1,227,636 sharesAverage Trading Volume791,411 sharesToday's Volume Vs. Average155% Short Selling Mangoceuticals ? Sign up to receive the latest short interest report for Mangoceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMGRX Short Interest Over TimeMGRX Days to Cover Over TimeMGRX Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. Mangoceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202445,700 shares $11,109.67 -76.9%0.3%0.1 $0.24 4/15/2024197,600 shares $48,214.40 -71.5%1.5%0.2 $0.24 3/31/2024692,100 shares $150,117.18 +364.2%5.3%0.6 $0.22 3/15/2024149,100 shares $26,405.61 +16.0%1.2%0.1 $0.18 2/29/2024128,500 shares $28,861.10 -81.0%1.1%0.1 $0.22 2/15/2024674,500 shares $158,844.75 +75.4%5.5%0.8 $0.24 Get the Latest News and Ratings for MGRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mangoceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024384,500 shares $138,804.50 +104.0%4.0%0.5 $0.36 1/15/2024188,500 shares $57,492.50 +195.0%2.6%0.3 $0.31 12/31/202363,900 shares $17,693.91 -57.9%0.9%0.1 $0.28 12/15/2023151,800 shares $46,602.60 +204.8%2.1%0.4 $0.31 11/30/202349,800 shares $36,802.20 +333.0%0.7%0.2 $0.74 11/15/202311,500 shares $5,012.85 -90.4%0.2%0 $0.44 10/31/2023120,300 shares $75,789.00 +620.4%1.7%0.5 $0.63 10/15/202316,700 shares $10,688.00 +153.0%0.2%0.1 $0.64 9/30/20236,600 shares $5,613.30 -82.8%0.1%0.1 $0.85 9/15/202338,400 shares $38,016.00 +18.5%0.6%0.4 $0.99 8/31/202332,400 shares $40,176.00 -22.5%0.5%0 $1.24 8/15/202341,800 shares $45,562.00 +5.8%0.6%0 $1.09 7/31/202339,500 shares $45,030.00 -13.9%0.6%0 $1.14 7/15/202345,900 shares $77,112.00 -51.9%0.8%0 $1.68 6/30/202395,400 shares $174,582.00 -79.6%1.6%0 $1.83 6/15/2023468,400 shares $726,020.00 +187.5%7.8%0.2 $1.55 5/31/2023162,900 shares $182,448.00 +10.4%2.9%0 $1.12 5/15/2023147,500 shares $181,425.00 No Change2.6%0 $1.23 MGRX Short Interest - Frequently Asked Questions What is Mangoceuticals' current short interest? Short interest is the volume of Mangoceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 45,700 shares of MGRX short. 0.32% of Mangoceuticals' shares are currently sold short. Learn More on Mangoceuticals' current short interest. What is a good short interest percentage for Mangoceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.32% of Mangoceuticals' floating shares are currently sold short. Is Mangoceuticals' short interest increasing or decreasing? Mangoceuticals saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 45,700 shares, a drop of 76.9% from the previous total of 197,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Mangoceuticals' float size? Mangoceuticals currently has issued a total of 24,620,000 shares. Some of Mangoceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mangoceuticals currently has a public float of 14,140,000 shares. How does Mangoceuticals' short interest compare to its competitors? 0.32% of Mangoceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Mangoceuticals: BioRestorative Therapies, Inc. (3.46%), Ontrak, Inc. (1.18%), ThermoGenesis Holdings, Inc. (0.64%), ETAO International Co., Ltd. (2.33%), Fresh Tracks Therapeutics, Inc. (0.17%), Vapotherm, Inc. (9.92%), Protagenic Therapeutics, Inc. (0.26%), Sonnet BioTherapeutics Holdings, Inc. (14.40%), Genprex, Inc. (2.46%), OpGen, Inc. (1.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Mangoceuticals stock? Short selling MGRX is an investing strategy that aims to generate trading profit from Mangoceuticals as its price is falling. MGRX shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mangoceuticals? A short squeeze for Mangoceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MGRX, which in turn drives the price of the stock up even further. How often is Mangoceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MGRX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: BRTX Short Squeeze OTRK Short Squeeze THMO Short Squeeze ETAO Short Squeeze FRTX Short Squeeze VAPO Short Squeeze PTIX Short Squeeze SONN Short Squeeze GNPX Short Squeeze OPGN Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MGRX) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchElon’s New Device is About to Shock the WorldInvestorPlaceMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders Alliance[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits